It was a busy week in the biotech sector, with many regulatory and pipeline updates. Neumora Therapeutics NMRA plummeted on ...

JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook.

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

US-based Lantheus Holdings becomes largest shareholder in Radiopharm Theranostics after US$5 million private placement.

The Genome India Project marks a defining moment in the country’s biotechnology landscape, My best wishes to those associated ...

Vir Biotechnology's recent share price rally is driven by their promising cancer program. Having shot to over a $1.5B market ...

In a major twist to the 2017 sensational Walayar rape case, the Central Bureau of Investigation (CBI), in the supplementary ...

Kochi:The Central Bureau of Investigation (CBI) has filed a chargesheet against the father and mother in the Walayar case, ...

KOCHI: In a major twist to the 2017 sensational case that rocked Kerala, the Central Bureau of Investigation (CBI), in the ...

Shares of the battered biotech Vir Biotechnology were up more than 70% on Wednesday, as the company reported its first ...

The Arch-backed startup begins life with several assets acquired from Denali Therapeutics. Elsewhere, Jasper got a negative ...